CAM
MRNA icon

Columbia Asset Management’s Moderna MRNA Stock Holding History

Columbia Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$563K Sell
2,215
-755
-25% -$221K 0.11% 111
2021
Q3 		$1.14M Sell
2,970
-1,515
-34% -$559K 0.25% 71
2021
Q2 		$1.05M Buy
+4,485
New +$802K 0.23% 77

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Columbia Asset Management's MRNA Position: Q4 2021 in Review

Columbia Asset Management reduced its Moderna (MRNA) stake by 25% in Q4 2021, selling an estimated $221K and leaving 2,215 shares worth $563K. The position accounts for 0.11% of the portfolio, ranked #111.

Columbia Asset Management first reported a position in MRNA in Q2 2021 and has held it in 3 quarters since. The position peaked at $1.14M in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Columbia Asset Management held 2,215 shares of Moderna worth $563K as of Q4 2021.
  • Columbia Asset Management sold 755 Moderna shares in Q4 2021, an estimated $221K.
  • Moderna made up 0.11% of Columbia Asset Management's portfolio in Q4 2021, its #111 holding.
  • Columbia Asset Management first reported a position in Moderna in Q2 2021 and has held it in 3 quarters since.
  • Columbia Asset Management's Moderna position peaked at $1.14M in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Columbia Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.